Characteristic | Coefficients | SE | P value | |
---|---|---|---|---|
Author numbers | 1 ~ 3 | Ref. | ||
4 ~ 6 | -1.555 | 1.665 | 0.354 | |
> 7 | -1.458 | 1.778 | 0.415 | |
Published year | 2009 ~ 2015 | Ref. | ||
2016 ~ 2018 | 1.065 | 1.662 | 0.524 | |
2019 ~ 2021 | 3.678 | 1.643 | 0.029 | |
Language | Chinese | Ref. | ||
English | 11.607 | 1.777 | < 0.001 | |
Method of economic evaluation | Cost-utility analysis | Ref. | ||
Cost-effectiveness analysis | -4.165 | 3.506 | 0.240 | |
Cost minimization analysis | -3.540 | 6.747 | 0.602 | |
Study design | Prospective Study | Ref. | ||
Retrospective Study | -4.331 | 4.250 | 0.312 | |
Modeling Study | 2.555 | 5.139 | 0.621 | |
Source of funding | No funding | Ref. | ||
Governmenta | 0.990 | 1.830 | 0.591 | |
Pharmaceutical company | 0.859 | 2.281 | 0.708 | |
Not mentioned | -4.469 | 2.035 | 0.032 | |
Study Perspective | Health insurance system | Ref. | ||
Healthcare system | 0.405 | 1.504 | 0.789 | |
Societal | -4.639 | 2.002 | 0.024 | |
Patient | 4.001 | 2.946 | 0.180 | |
Health Care Provider | -5.073 | 5.223 | 0.335 | |
Not mentioned | -11.173 | 3.435 | 0.002 | |
Time horizon | Not mentioned | Ref. | ||
< 1 year | -3.706 | 5.541 | 0.506 | |
1–5 year | 1.618 | 2.120 | 0.448 | |
6–10 year | 0.470 | 2.223 | 0.833 | |
> 10 year | 2.427 | 2.454 | 0.327 | |
Constant | 67.686 | 5.808 | < 0.001 |